Biblio
Export 380 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is E [Clear All Filters]
“Metabolites Associated with Early Cognitive Changes Implicated in Alzheimer's Disease.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1041-1054, 2021.
, “Needs of Dementia Family Caregivers in Spain During the COVID-19 Pandemic.”, J Alzheimers Dis, vol. 80, no. 2, pp. 533-537, 2021.
, “Neuropsychiatric Symptoms in Patients with Neurocognitive Disorder and Their Performance Between Mild and Major Stages.”, J Alzheimers Dis, vol. 85, no. 4, pp. 1735-1744, 2021.
, “Pharmacological Strategies to Improve Dendritic Spines in Alzheimer's Disease.”, J Alzheimers Dis, vol. 82, no. s1, pp. S91-S107, 2021.
, “Pharmacological Strategies to Improve Dendritic Spines in Alzheimer's Disease.”, J Alzheimers Dis, vol. 82, no. s1, pp. S91-S107, 2021.
, “Plasma Biomarkers of Alzheimer's Disease in African Americans.”, J Alzheimers Dis, vol. 79, no. 1, pp. 323-334, 2021.
, “Preventing Delirium and Promoting Long-Term Brain Health: A Clinical Trial Design for the Perioperative Cognitive Enhancement (PROTECT) Trial.”, J Alzheimers Dis, vol. 83, no. 4, pp. 1637-1649, 2021.
, “Quality of Life in Advanced Dementia with Late Onset, Young Onset, and Very Young Onset.”, J Alzheimers Dis, vol. 80, no. 1, pp. 283-297, 2021.
, “Race/Ethnic Disparities in Mild Cognitive Impairment and Dementia: The Northern Manhattan Study.”, J Alzheimers Dis, vol. 80, no. 3, pp. 1129-1138, 2021.
, “Relevance of a Truncated PRESENILIN 2 Transcript to Alzheimer's Disease and Neurodegeneration.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1479-1489, 2021.
, “The Right Temporal Variant of Frontotemporal Dementia Is Not Genetically Sporadic: A Case Series.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1195-1201, 2021.
, “Soluble Amyloid-β Consumption in Alzheimer's Disease.”, J Alzheimers Dis, vol. 82, no. 4, pp. 1403-1415, 2021.
, “Soluble Amyloid-β Consumption in Alzheimer's Disease.”, J Alzheimers Dis, vol. 82, no. 4, pp. 1403-1415, 2021.
, “Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1629-1642, 2021.
, “Alzheimer's Disease with Epileptiform EEG Activity: Abnormal Cortical Sources of Resting State Delta Rhythms in Patients with Amnesic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 88, no. 3, pp. 903-931, 2022.
, “Association of Cholinergic Basal Forebrain Volume and Functional Connectivity with Markers of Inflammatory Response in the Alzheimer's Disease Spectrum.”, J Alzheimers Dis, vol. 85, no. 3, pp. 1267-1282, 2022.
, “Associations of Pulmonary Function with MRI Brain Volumes: A Coordinated Multi-Study Analysis.”, J Alzheimers Dis, vol. 90, no. 3, pp. 1073-1083, 2022.
, “Behavioral and Psychological Symptoms of Dementia in Different Dementia Disorders: A Large-Scale Study of 10,000 Individuals.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1307-1318, 2022.
, “Blood Pressure and Later-Life Cognition in Hispanic and White Adults (BP-COG): A Pooled Cohort Analysis of ARIC, CARDIA, CHS, FOS, MESA, and NOMAS.”, J Alzheimers Dis, vol. 89, no. 3, pp. 1103-1117, 2022.
, “Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old.”, J Alzheimers Dis, vol. 90, no. 1, pp. 405-417, 2022.
, “Cerebrospinal Fluid Sphingomyelins in Alzheimer's Disease, Neurodegeneration, and Neuroinflammation.”, J Alzheimers Dis, vol. 90, no. 2, pp. 667-680, 2022.
, “Digital Technologies to Prevent Social Isolation and Loneliness in Dementia: A Systematic Review.”, J Alzheimers Dis, vol. 90, no. 2, pp. 513-528, 2022.
, “Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled Trial.”, J Alzheimers Dis, vol. 88, no. 1, pp. 75-95, 2022.
, “Frontal Atrophy and Executive Dysfunction Relate to Complex Numbers Impairment in Progressive Supranuclear Palsy.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1553-1566, 2022.
, “High Soluble Amyloid-β42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer's Disease-Causing Mutations.”, J Alzheimers Dis, vol. 90, no. 1, pp. 333-348, 2022.
,